Evidence map›Paper›PMID 22251169›Full record

ArticleJournal of neurochemistry2012

Attenuation of neonatal ischemic brain damage using a 20-HETE synthesis inhibitor.

Zeng-Jin Yang, Erin L Carter, Kathleen K Kibler, Herman Kwansa, Daina A Crafa, Lee J Martin, Richard J Roman, David R Harder, Raymond C Koehler

Abstract readComparative Study
In one paragraph

Article in Journal of neurochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Neuroprotection provided by hypothermia initiated with high transnasal flow with ambient air in a model of pediatric cardiac arrest.American journal of physiology. Regulatory, integrative and comparative physiology · 2024
    Article
  3. Review
  4. Article
  5. Candidate neuroinflammatory markers of cerebral autoregulation dysfunction in human acute brain injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. 20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Article
  15. Article
  16. Perinatal hypoxic-ischemic brain injury in large animal models: Relevance to human neonatal encephalopathy.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zeng-Jin YangDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD 21205, USA. zyang4@jhmi.edu
Erin L Carter
Kathleen K Kibler
Herman Kwansa
Daina A Crafa
Lee J Martin
Richard J Roman
David R Harder
Raymond C Koehler
Johns Hopkins University · USMedical College of Wisconsin · USUniversity of Mississippi Medical Center · US

Funding

Role of Novel CYP Isoforms in Regulation of Cerebral Blood FlowP01HL059996 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI ROMAN, RICHARD J. · 1999 to 2009
$14.5M
REGULATING CEREBRAL MICROCIRCULATION BY ASTROCYTESR01HL033833 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HARDER, DAVID RAE · 1985 to 2017
$5.8M
Therapeutic Strategies for Neonatal Hypoxic-Ischemiic EncephalopathyR01NS060703 · NINDS · JOHNS HOPKINS UNIVERSITY · PI KOEHLER, RAYMOND CHARLES · 2008 to 2019
$3.9M
Modification of Vascular Signaling in the Brain by ROSR01HL092105 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HARDER, DAVID RAE · 2009 to 2013
$2.0M
CELLULAR CONTROL MECHANISMS OF CEREBROVASCULAR TONER37HL033833 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HARDER, DAVID R · 1990 to 1999
–
NHLBI NIH HHS HL033833NHLBI NIH HHS HL059996NHLBI NIH HHS HL092105NHLBI NIH HHS P01 HL059996NHLBI NIH HHS R01 HL033833NHLBI NIH HHS R01 HL092105NHLBI NIH HHS R37 HL033833NINDS NIH HHS NS060703NINDS NIH HHS R01 NS060703
6 · The paper itself

Abstract

20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P450 metabolite of arachidonic acid that that contributes to infarct size following focal cerebral ischemia. However, little is known about the role of 20-HETE in global cerebral ischemia or neonatal hypoxia-ischemia (H-I). The present study examined the effects of blockade of the synthesis of 20-HETE with N-hydroxy-N'-(4-n-butyl-2-methylphenyl) formamidine (HET0016) in neonatal piglets after H-I to determine if it protects highly vulnerable striatal neurons. Administration of HET0016 after H-I improved early neurological recovery and protected neurons in putamen after 4 days of recovery. HET0016 had no significant effect on cerebral blood flow. cytochrome P450 4A immunoreactivity was detected in putamen neurons, and direct infusion of 20-HETE in the putamen increased phosphorylation of Na(+), K(+) -ATPase and NMDA receptor NR1 subunit selectively at protein kinase C-sensitive sites but not at protein kinase A-sensitive sites. HET0016 selectively inhibited the H-I induced phosphorylation at these same sites at 3 h of recovery and improved Na(+), K(+) -ATPase activity. At 3 h, HET0016 also suppressed H-I induced extracellular signal-regulated kinase 1/2 activation and protein markers of nitrosative and oxidative stress. Thus, 20-HETE can exert direct effects on key proteins involved in neuronal excitotoxicity in vivo and contributes to neurodegeneration after global cerebral ischemia in immature brain.

Indexed as

AmidinesAnimalsAnimals, NewbornBrain IschemiaHydroxyeicosatetraenoic AcidsInfusions, IntraventricularMaleSwine20-hydroxy-5,8,11,14-eicosatetraenoic acidAmidinesHET0016Hydroxyeicosatetraenoic Acids

Identifiers

PMID22251169
PMCPMC3303996
OpenAlexW1590044907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.